hypochlorous acid (PR013)
/ XenoTherapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 29, 2019
Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis
(clinicaltrials.gov)
- P2; N=96; Completed; Sponsor: Realm Therapeutics, Inc.; Recruiting ➔ Completed
Trial completion
1 to 1
Of
1
Go to page
1